Yi Chen
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 1%
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
Papers in
-
- Cancer-related molecular mechanisms research 35
- MicroRNA in disease regulation 29
- Hepatology 23
- Hepatocellular Carcinoma Treatment and Prognosis 13
Yi Chen
353 papers receiving 9.2k citations
Hit Papers
Peers
Comparison fields: 5 of 178
- Cancer Research 1.9k
- Molecular Biology 4.2k
- Geriatrics and Gerontology 232
- Hepatology 432
- Oncology 1.1k
Countries citing papers authored by Yi Chen
This map shows the geographic impact of Yi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Chen more than expected).
Fields of papers citing papers by Yi Chen
This network shows the impact of papers produced by Yi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Chen. The network helps show where Yi Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yi Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 11 | |
| 6 | 2024 | 13 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 5 | |
| 10 | 2022 | 7 | |
| 11 | 2021 | 47 | |
| 12 | 2020 | 114 | |
| 13 | Ginkgo biloba extract-761 protects myocardium by regulating Akt/Nrf2 signal pathway | 2019 | 3 |
| 14 | Effect of tea polyphenols combined with photodynamic therapy on the efficacy and RANKL and Shh levels in patients with early periimplantitis | 2019 | 2 |
| 15 | 2019 | 35 | |
| 16 | 2018 | 204 | |
| 17 | 2018 | 98 | |
| 18 | 2013 | 85 | |
| 19 | 2010 | 117 | |
| 20 | 2010 | 227 |
About Yi Chen
Yi Chen is a scholar working on Cancer Research, Hepatology, Molecular Biology, Epidemiology and Geriatrics and Gerontology, having authored 371 papers that have together received 9.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (35 papers), MicroRNA in disease regulation (29 papers), Circular RNAs in diseases (20 papers), Autophagy in Disease and Therapy (19 papers), Liver Disease Diagnosis and Treatment (18 papers), RNA modifications and cancer (15 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers) and Luminescence and Fluorescent Materials (13 papers). The work is most often cited by research in Cancer Research (1.9k citations), Molecular Biology (4.2k citations), Geriatrics and Gerontology (232 citations), Hepatology (432 citations) and Oncology (1.1k citations). Yi Chen has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Bo Liu, Leilei Fu, Minru Liao, Shiou Zhu, Liang Ouyang, Bo Han, Cheng Peng, Peng Fu, Rui Qin and Honggang Xiang. Their work appears in journals such as PLoS ONE, Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Cancer Research and Frontiers in Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.